— Know what they know.
Not Investment Advice
Also trades as: GOVXW (NASDAQ) · $vol 0M

GOVX NASDAQ

GeoVax Labs, Inc.
1W: -6.5% 1M: -40.6% 3M: -73.8% YTD: -93.7% 1Y: -97.6% 3Y: -99.8% 5Y: -100.0%
$0.32
-0.00 (-0.65%)
 
Weekly Expected Move ±6.9%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 24 · $2.4M mcap · 7M float · 70.90% daily turnover · Short 40% of daily vol

Balance Sheet Trends

Total Assets
$8M -12.1% ▼
5Y CAGR: +77.0%
Total Liabilities
$3M -11.7% ▼
5Y CAGR: +8.7%
Shareholders Equity
$5M -12.4% ▼
Cash & Investments
$6M -14.7% ▼
5Y CAGR: +81.0%
Total Debt
$0 +0.0% ▲
Net Debt
-$6M +14.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$10M$11M$28M$6M$6M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$10M$11M$28M$6M$6M
Net Receivables$183K$49K$0$0$659K
Inventory$0-$49K$0$0$0
Other Current Assets-$352$49K$0$0$0
Total Current Assets$10M$12M$29M$8M$8M
Property, Plant & Equip.$159K$168K$2M$210K$150K
Goodwill & Intangibles$0$0$80K$70K$60K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0-$80K$1M$11K
Total Non-Current Assets$159K$168K$2M$1M$221K
Total Assets$10M$12M$31M$9M$8M
— Liabilities —
Accounts Payable$268K$2M$2M$3M$2M
Short-Term Debt$183K$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$0$271K
Total Current Liabilities$810K$5M$5M$4M$3M
Long-Term Debt$15K$0$0$0$0
Other Non-Current Liab.$0$2M$0$0$0
Total Non-Current Liabilities$15K$2M$0$0$0
Total Liabilities$825K$7M$5M$4M$3M
— Equity —
Common Stock$4K$6K$26K$2K$11K
Retained Earnings-$46M-$64M-$78M-$104M-$129M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$10M$4M$27M$6M$5M
Total Liabilities & Equity$10M$12M$31M$9M$8M
— Key Metrics —
Total Debt$198K$0$0$0$0
Net Debt-$10M-$11M-$28M-$6M-$6M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms